Position
Chief Financial Officer
Company
Lexeo Therapeutics
New York CityBiotechnologyHealth CareGeneticsTherapeuticsDescription
Lexeo Therapeutics, Inc. announced the appointment of Dr. Kyle Rasbach as the Chief Financial Officer
Quick answer
Lexeo Therapeutics Appoints Dr. Kyle Rasbach as Chief Financial Officer (December 19, 2024). Lexeo Therapeutics is based in New York City, New York, United States.
- Who is the new Chief Financial Officer at Lexeo Therapeutics?
- Lexeo Therapeutics named Kyle Rasbach Chief Financial Officer, announced December 19, 2024.
- What did Lexeo Therapeutics announce on December 19, 2024?
- Lexeo Therapeutics, Inc. announced the appointment of Dr. Kyle Rasbach as the Chief Financial Officer
- What does Lexeo Therapeutics do?
- Lexeo Therapeutics is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated.
- Where is Lexeo Therapeutics based?
- Lexeo Therapeutics is based in New York City, New York, United States.
- Which similar companies made leadership changes around the same time?
- Franklin Biolabs (December 4, 2024), Precision BioSciences (January 29, 2025), NYU Langone Health (December 20, 2024) and EXICURE, INC. (December 20, 2024) also announced leadership changes within 45 days of Lexeo Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Genetics and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Franklin Biolabs Names Vatsala Naageshwaran as Chief Executive Officer (December 4, 2024)
- Precision BioSciences Appoints Cindy Atwell as Chief Development and Business Officer and Cassie Gorsuch, PhD as Chief Scientific Officer (January 29, 2025)
- Perlmutter Cancer Center Appoints Dr. Anne S. Renteria as Site Director for Transplantation and Cellular Therapy Center (December 20, 2024)
- Exicure, Inc. Appoints Two New Directors and Receives Significant Investments from HiTron and SangSang (December 20, 2024)
- VectorY Appoints Jim Scibetta as CEO (December 16, 2024)
- Xilio Therapeutics Appoints Caroline (Holda) Hensley as Chief Legal Officer (December 16, 2024)
Who to call at Lexeo Therapeutics, and when
A new leader at Lexeo Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Lexeo Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lexeo Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lexeo Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lexeo Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Lexeo Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.